Effects of Anti-TSLP in Patients With Asthma

NCT02698501 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Asthma

Interventions

DRUG: MEDI9929
DRUG: Placebo

Sponsor

Celeste Porsbjerg

Collaborators

[object Object]
[object Object]
[object Object]